Orpea S.A. (ORRRY)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Orpea S.A. (ORRRY) trades at $0.30 with AI Score 45/100 (Grade C). Orpea S. A. is a global operator of nursing homes, assisted-living facilities, and rehabilitation hospitals. Market cap: $371.54M, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for ORRRY: ORRRY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ORRRY against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ORRRY: the 1 perspectives are evenly split.
How is this calculated? →Orpea S.A. (ORRRY) Healthcare & Pipeline Overview
Orpea S.A., a global healthcare provider based in France, operates nursing homes, assisted-living facilities, and rehabilitation hospitals. With a focus on elderly care and rehabilitation services across multiple countries, Orpea faces challenges in a competitive and regulated healthcare landscape while navigating financial performance issues reflected in its negative profit margin.
What Is the Investment Thesis for ORRRY?
Orpea S.A. presents a complex investment case. The company's global presence in the growing elderly care market offers long-term potential, driven by demographic trends and increasing demand for specialized care facilities. However, Orpea's negative profit margin of -5.1% and negative P/E ratio of -4.62 raise concerns about its financial performance. The company's beta of 0.76 suggests lower volatility compared to the market. Successful execution of its restructuring plans and improved operational efficiency are critical for restoring profitability and investor confidence. Monitoring key metrics such as occupancy rates, cost management, and regulatory compliance is essential for assessing Orpea's investment viability.
Based on FMP financials and quantitative analysis
ORRRY Key Highlights
- Market capitalization of $371.54M reflects investor valuation of Orpea S.A.
- Negative P/E ratio of -4.62 indicates current unprofitability.
- Profit margin of -5.1% highlights challenges in achieving profitability.
- Gross margin of 2.2% suggests limited pricing power or high cost of services.
- Beta of 0.76 indicates lower volatility compared to the overall market.
Who Are ORRRY's Competitors?
ORRRY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BTMD biote Corp. | $2.25 | +3.92% | $99.46M | 74 |
| CSSPF NIOX Group Plc | $0.75 | +0.00% | $315.65M | 47 |
| DFHL Dong Fang Hui Le Inc. | $4.00 | -11.11% | $400.40M | 44 |
| GUERF Guerbet S.A. | $22.25 | +0.00% | $281.03M | 43 |
| HYBT Heyu Biological Technology Corporation | $0.35 | -41.67% | $361.36M | 42 |
| HWAIF Healwell AI Inc. | $0.53 | -3.52% | $160.75M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ORRRY's Key Strengths?
- Global presence and diversified operations.
- Comprehensive range of healthcare services.
- Experienced management team.
- Established relationships with payers.
What Are ORRRY's Weaknesses?
- Negative profit margin.
- High debt levels.
- Exposure to regulatory risks.
- Reputational risks.
What Could Drive ORRRY Stock Higher?
- Implementation of restructuring plans to improve financial performance.
- Expansion of specialized care services to attract a higher paying customer base.
- Potential acquisitions of smaller care facilities to expand geographic footprint.
- Technological innovation to improve efficiency and quality of services.
- Expansion of home care services to cater to the growing demand for in-home care.
What Are the Key Risks for ORRRY?
- Financial-distress signal — its Altman Z-Score of 0.17 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-19.9%) — the business is not currently generating profit on shareholder capital.
- Negative profit margin and high debt levels.
- Changes in government regulations and reimbursement models.
- Increasing competition from other healthcare providers.
- Economic downturns affecting demand for services.
- Reputational risks associated with quality of care and ethical practices.
What Are the Growth Opportunities for ORRRY?
- Expansion into emerging markets: Orpea can capitalize on the growing demand for elderly care services in emerging markets such as Brazil, Russia, and China. These markets offer significant growth potential due to their large populations and increasing healthcare spending. Successful entry and adaptation to local regulations and cultural nuances are crucial for success. This expansion could contribute significantly to revenue growth over the next 5-10 years.
- Development of specialized care services: Orpea can enhance its service offerings by developing specialized care programs for specific conditions such as dementia, Alzheimer's disease, and Parkinson's disease. These specialized programs can attract a higher paying customer base and differentiate Orpea from its competitors. The market for specialized care services is expected to grow significantly in the coming years, driven by the increasing prevalence of these conditions. Timeline for implementation is 2-3 years.
- Strategic acquisitions: Orpea can pursue strategic acquisitions of smaller care facilities and regional operators to expand its geographic footprint and market share. Acquisitions can provide access to new markets, technologies, and talent. Careful due diligence and integration are essential for realizing the full benefits of acquisitions. This strategy could yield significant growth within 3-5 years.
- Technological innovation: Orpea can invest in technological innovation to improve the efficiency and quality of its services. This includes implementing electronic health records, telemedicine solutions, and remote monitoring devices. Technology can help to reduce costs, improve patient outcomes, and enhance the overall care experience. Implementation of these technologies can begin immediately and show results within 1-2 years.
- Enhanced home care services: Orpea can expand its home care services to cater to the growing demand for in-home care. Home care services offer a more affordable and convenient alternative to facility-based care for many elderly individuals. Orpea can leverage its existing infrastructure and expertise to provide high-quality home care services. This expansion can be implemented within the next year and contribute to revenue growth over the long term.
What Opportunities Does ORRRY Have?
- Expansion into emerging markets.
- Development of specialized care services.
- Strategic acquisitions.
- Technological innovation.
What Threats Does ORRRY Face?
- Increasing competition.
- Changes in government regulations.
- Economic downturns.
- Labor shortages.
What Are ORRRY's Competitive Advantages?
- Established brand reputation in the healthcare industry.
- Extensive network of facilities across multiple countries.
- Specialized expertise in elderly care and rehabilitation services.
- Long-term relationships with insurance companies and government programs.
What Does ORRRY Do?
Founded in 1989, Orpea S.A. has grown into a multinational healthcare provider specializing in long-term care and rehabilitation services. Headquartered in Puteaux, France, the company operates a network of nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals across Europe, Latin America, and Asia. Orpea's facilities provide a comprehensive range of services, including accommodation, meals, personalized support, and specialized medical care for elderly and dependent individuals. The company's post-acute and rehabilitation hospitals offer services for various conditions, including geriatrics, musculoskeletal, nervous system, and cardiovascular issues. Its psychiatric hospitals cater to patients with mood disorders, anxiety disorders, and other mental health conditions. In addition to facility-based care, Orpea also offers home care services, including housekeeping, daily life assistance, and movement assistance. With operations in over 20 countries, Orpea has established a significant presence in the global healthcare market, employing approximately 76,000 people.
What Products and Services Does ORRRY Offer?
- Operates nursing homes providing personalized support services.
- Manages assisted-living facilities for elderly individuals.
- Runs post-acute and rehabilitation hospitals for various medical conditions.
- Offers psychiatric hospital services for patients with mental health disorders.
- Provides home care services including housekeeping and daily life assistance.
- Offers accommodation, meals, and laundry services in its facilities.
- Organizes daily events, entertainment, and therapeutic workshops for residents.
How Does ORRRY Make Money?
- Generates revenue from accommodation and care services provided in its facilities.
- Receives payments from residents, insurance companies, and government programs.
- Offers a range of services including medical care, rehabilitation, and assisted living.
- Expands its network through acquisitions and development of new facilities.
What Industry Does ORRRY Operate In?
Orpea S.A. operates within the medical care facilities industry, which is experiencing growth due to the aging global population and increasing demand for long-term care services. The industry is characterized by a mix of public and private providers, with varying levels of regulation and reimbursement models. Key competitors include BTMD (BioTelemetry Inc.), CSSPF (Care Solutions Holding SA), DFHL (Dahongli Investment Holding Co Ltd), GUERF (Guerbet SA), and HYBT (Hybertone Corporation). Orpea's success depends on its ability to provide high-quality care, manage costs effectively, and navigate the complex regulatory landscape in each of its operating countries. The industry is also facing increasing scrutiny regarding quality of care and ethical practices.
Who Are ORRRY's Key Customers?
- Elderly individuals requiring long-term care.
- Patients needing post-acute and rehabilitation services.
- Individuals with mental health disorders seeking psychiatric care.
- Families seeking care solutions for their loved ones.
How Orpea S.A. Is Valued
Orpea S.A. carries a market capitalization of $371.54M, placing it in the small-cap category. Relative to its peer group, ORRRY's quantitative score of 45/100 is roughly in line with the peer average of 50/100.
ROE -20%Key Financial Metrics
Return on equity for Orpea S.A. stands at -19.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -2.4%, showing how much profit it generates from its asset base. Its free cash flow yield is 31.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.59 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -22.1%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 4/9Financial Health
Orpea S.A.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.17 places it in the distress zone, a signal of elevated financial risk.
ORRRY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Global presence and diversified operations.
- Comprehensive range of healthcare services.
- Experienced management team.
- Established relationships with payers.
Bear Case
- Negative profit margin.
- High debt levels.
- Exposure to regulatory risks.
- Reputational risks.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
ORRRY Latest News
No recent news available for ORRRY.
ORRRY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ORRRY.
Price Targets
Wall Street price target analysis for ORRRY.
ORRRY MoonshotScore
What does this score mean?
The MoonshotScore rates ORRRY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Laurent Guillot
CEO
Laurent Guillot is the CEO of Orpea S.A. His background includes extensive experience in managing large organizations and driving strategic growth. Prior to joining Orpea, he held leadership positions in various multinational companies, focusing on operational efficiency and business development. He is known for his expertise in navigating complex regulatory environments and implementing successful turnaround strategies. His educational background includes advanced degrees in business administration and engineering.
Track Record: Since assuming the role of CEO, Laurent Guillot has focused on restructuring Orpea's operations and restoring investor confidence. Key initiatives include implementing cost-saving measures, improving quality of care, and strengthening relationships with regulatory authorities. He has also overseen the development of new strategic partnerships and the expansion of Orpea's services in key markets. His leadership is aimed at driving sustainable growth and enhancing shareholder value.
Orpea S.A. ADR Information Unsponsored
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company that trades on U.S. stock exchanges. ORRRY, as an ADR, allows U.S. investors to invest in Orpea S.A. without the complexities of cross-border transactions. The ADR is denominated in U.S. dollars, simplifying trading and reporting for U.S. investors. The underlying shares are held by a custodian bank in the home country, France.
- Home Market Ticker: Euronext Paris, France
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: ORRR
ORRRY OTC Market Information
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure and may not meet the listing requirements of major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for limited liquidity, price volatility, and lack of regulatory oversight compared to exchange-listed stocks. Investors should exercise caution and conduct thorough due diligence before investing in ORRRY.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Potential for price manipulation.
- Higher risk of fraud.
- Lower liquidity.
- Lack of regulatory oversight.
- Verify the company's registration and legal status.
- Obtain and review available financial statements.
- Assess the company's management team and track record.
- Research the company's industry and competitive landscape.
- Evaluate the company's risk factors.
- Understand the OTC market and its associated risks.
- Consult with a qualified financial advisor.
- Positive news coverage and media mentions.
- Partnerships with reputable organizations.
- Active engagement with investors and stakeholders.
- Clear and transparent communication.
- Compliance with applicable laws and regulations.
ORRRY Healthcare Stock FAQ
What does Orpea S.A. do?
Orpea S.A. is a global healthcare provider specializing in long-term care and rehabilitation services. The company operates a network of nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals across Europe, Latin America, and Asia. Orpea's facilities provide a comprehensive range of services, including accommodation, meals, personalized support, and specialized medical care for elderly and dependent individuals. In addition to facility-based care, Orpea also offers home care services.
What are the main risks for ORRRY?
The main risks for ORRRY include its negative profit margin and high debt levels, which raise concerns about its financial sustainability. Changes in government regulations and reimbursement models could also negatively impact its revenue and profitability. Increasing competition from other healthcare providers and economic downturns could further challenge its growth prospects. Reputational risks associated with quality of care and ethical practices are also a significant concern. Investors should carefully consider these risks before investing in ORRRY.
What are the key factors to evaluate for ORRRY?
Orpea S.A. (ORRRY) holds an AI score of 45/100 (low). Not financial advice.
How frequently does ORRRY data refresh on this page?
ORRRY prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ORRRY's recent stock price performance?
Orpea S.A. (ORRRY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Global presence and diversified operations. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ORRRY overvalued or undervalued right now?
Valuing Orpea S.A. (ORRRY) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying ORRRY?
Before investing in Orpea S.A. (ORRRY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding ORRRY to a portfolio?
Key strength of Orpea S.A. (ORRRY): Global presence and diversified operations. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data may be outdated or incomplete.
- AI analysis is pending and may provide additional insights.
- OTC market investments carry higher risks.